References
- Li W, Gao Z, Yang C, Li J, Li L, Lv R, et al. 2013. The estimation of prevalence, incidence, and residual risk of transfusion-transmitted human hepatitis B infection from blood donated at the Anhui blood center, China, from 2009 to 2011. PLoS One 8: e73472. https://doi.org/10.1371/journal.pone.0073472
- Chen YS, Li L, Cui FQ, Xing WG, Wang L, Jia ZY, et al. 2011. [A seroepidemiological study on hepatitis C in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 32: 888-891.
- Yong Hao G, Da Xing F, Jin X, Xiu Hong F, Pu Mei D, Jun L, et al. 2017. The prevalence of hepatitis B infection in central China: An adult population-based serological survey of a large sample size. J. Med. Virol. 89: 450-457. https://doi.org/10.1002/jmv.24649
- Li L, Han T, Zang L, Niu L, Cheng W, Lin H, et al. 2017. The current incidence, prevalence, and residual risk of hepatitis B viral infections among voluntary blood donors in China. BMC Infect Dis. 17: 754. https://doi.org/10.1186/s12879-017-2861-3
- Chen P, Xie Q, Chen T, Wu J, Wu J, Ruan B, et al. 2017. Hepatitis B virus infection in hilly/mountainous regions of southeastern China: a locality-dependent epidemiology. BMC Infect Dis. 17: 809. https://doi.org/10.1186/s12879-017-2922-7
- Luo Z, Xie Y, Deng M, Zhou X, Ruan B. 2011. Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size. Eur. J .Gastroenterol. Hepatol. 23: 695-700. https://doi.org/10.1097/MEG.0b013e328347322b
- Makvandi M. 2016. Update on occult hepatitis B virus infection. World J. Gastroenterol. 22: 8720-8734. https://doi.org/10.3748/wjg.v22.i39.8720
- Zu J, Zhuang G, Liang P, Cui F, Wang F, Zheng H, et al. 2017. Estimating age-related incidence of HBsAg seroclearance in chronic hepatitis B virus infections of China by using a dynamic compartmental model. Sci Rep. 7: 2912. https://doi.org/10.1038/s41598-017-03080-6
- Goyal A, Murray JM. 2017. Roadmap to control HBV and HDV epidemics in China. J. Theor. Biol. 423: 41-52. https://doi.org/10.1016/j.jtbi.2017.04.007